Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal s
administrator
Related Articles
2024 Safety Communications
- September 10, 2025
One Frozen, LLC Voluntarily Recalls Good & Gather™…
- September 10, 2025
Chetak LLC Group Expands Voluntary Product Recall to…
- September 10, 2025